PHD Discussions Logo

Ask, Learn and Accelerate in your PhD Research

Question Icon Post Your Answer

Question Icon

How can the potential risks associated with genetic applications be minimized through ethical governance and practice?

We can identify risks like off-target effects or genetic discrimination, but my committee is asking for proactive, ethical mitigation strategies. What specific steps in research design, consent processes, and long-term monitoring constitute an ethically robust risk minimization protocol?

All Answers (1 Answers In All)

By Bindya Answered 1 year ago

Ethical risk minimization requires a multi-layered approach. First, it demands iterative, transparent safety testing in pre-clinical phases to characterize risks like off-target effects. Second, it involves dynamic consent processes that inform participants of new risks as they emerge. Third, establishing independent, multidisciplinary oversight committees with enforcement power is crucial for ongoing review. Finally, creating long-term outcome registries for interventions like gene therapy ensures post-trial monitoring. From my advisory role, the key is embedding these steps within a governance culture that prioritizes precaution and public accountability, not just technical compliance.

 

Your Answer